Navigation

Nestlé to buy Pfizer’s infant-nutrition business

Swiss food and drink giant Nestlé has announced a deal to acquire Pfizer’s infant-nutrition business for $11.85 billion (SFr10.8 billion).

This content was published on April 23, 2012 - 09:26
swissinfo.ch and agencies

The Vevey-based company says the acquisition, subject to regulatory approval, would “enhance its position in global infant nutrition”.

Nestlé CEO Paul Bulcke called the deal to buy the Pfizer nutrition unit “an excellent strategic fit”.

Nestlé said in a statement on Monday that estimated sales from the acquired business would be $2.4 billion in 2012.

It said 85 per cent of those sales are in emerging markets, many of which have large, fast-growing populations.

Nestlé is one of the world’s largest sellers of infant formula and may face some antitrust hurdles to complete the deal.

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

Sort by

Change your password

Do you really want to delete your profile?

Your subscription could not be saved. Please try again.
Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.

Discover our weekly must-reads for free!

Sign up to get our top stories straight into your mailbox.

The SBC Privacy Policy provides additional information on how your data is processed.